Results 231 to 240 of about 489,421 (410)

Clinical profile, short and long‐term outcomes of non‐ischaemic cardiogenic shock: A FRENSHOCK sub‐analysis

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Although predominant in routine practice, non‐ischaemic cardiogenic shock (NICS) remains underrepresented in past studies, mainly focused on ischaemic cardiogenic shock (CS). This study aims to describe the current NICS picture and define its independent correlates of short‐ and long‐term outcomes.
Miloud Cherbi   +20 more
wiley   +1 more source

Identification of a SARS-CoV-2 virus-encoded small non-coding RNA in association with the neurological disorders in COVID-19 patients

open access: yesSignal Transduction and Targeted Therapy, 2022
Qian Zhao   +11 more
doaj   +1 more source

The relevance of β‐receptor blockade to ouabain‐induced cardiac arrhythmias [PDF]

open access: green, 1969
A N Dohadwalla   +2 more
openalex   +1 more source

Long‐term outcomes of electrical storm patients listed for urgent heart transplantation but not transplanted acutely

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Refractory electrical storm (ES) is a life‐threatening condition in which heart transplantation (HTx) can be proposed. Nevertheless, the shortage of donors and subsequent outcomes question its place as a rescue strategy. We aim to describe the prognosis of ES patients listed for HTx but not transplanted.
Miloud Cherbi   +11 more
wiley   +1 more source

Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Renin–angiotensin–aldosterone system inhibitors (RAASi) are foundational in the management of heart failure (HF) and chronic kidney disease (CKD) but increase the risk of hyperkalaemia. To facilitate continuation of RAASi therapy, guidelines suggest managing hyperkalaemia using newer potassium binders such as sodium zirconium ...
Charles V. Pollack Jr.   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy